Login / Signup

Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway.

Yun FengLinlin WangXiaoying MaXiaotong YangOcholi DonXiaoyan ChenJieming QuYuanlin Song
Published in: Stem cell research & therapy (2020)
These results reveal that the combination of hCMSCs and liraglutide might be an effective strategy for ALI treatment.
Keyphrases
  • genome wide
  • single cell
  • binding protein
  • dna methylation
  • combination therapy
  • replacement therapy